News

Shares of a little-known biotechnology stock called Metsera (NASDAQ: MTSR) popped on Monday, Sept. 22, after Pfizer (NYSE: PFE) announced it would be acquiring it for a steep premium. Under the

Strong dividend payers can be a stabilizing force in a well-diversified portfolio. That's because corporations that can consistently pay and raise their payouts over a long period are often

A victory on the regulatory front and a bullish analyst move were the twin news items propelling BioNTech's (NASDAQ: BNTX) shares higher as the stock trading week began on Monday. The Germany-based

Pfizer (NYSE: PFE), the one-time COVID vaccine hero turned Ozempic craze zero, is marching higher Monday after announcing it will try to recover from its danuglipron setback by buying another drug

It isn't easy to find a pharmaceutical company that has a strong product lineup and a robust pipeline, but also cranks out a generous dividend every quarter. I've been an AbbVie (NYSE: ABBV) bull

The major market indexes are bumping against all-time highs. It's not surprising, therefore, that many stocks are trading at steep valuations. There are, however, some exceptions that are still

Medtronic (NYSE: MDT) is out of favor today, noting it has a historically high dividend yield of around 3%. The company is working on improving its business performance, however, and stronger

President Donald Trump's trade policies have introduced plenty of volatility to the stock market this year. Steeper tariffs could impact consumer spending and the broader economy in ways that could

UnitedHealth Group (NYSE: UNH) stock has been one of the most interesting on Wall Street in the last few weeks. Following a brutal start to the year, the healthcare provider was the No. 1 performing

A bargain stock can be a great opportunity if you subscribe to the value approach to investing. If a stock is trading at a cheap price, but the company has strong business fundamentals and solid

According to some research, healthcare stocks are about as cheap as they have been in three decades. Many have experienced significant headwinds recently, but for opportunistic investors, now may be

It is tempting for a dividend investor to simply select the highest yielding stocks. The problem with that approach is that it exposes you to the risk of dividend cuts if the yield is too high for

Investors who bought shares of Intuitive Surgical (NASDAQ: ISRG) or Vertex Pharmaceuticals (NASDAQ: VRTX) 20 years ago and held onto them are likely pleased with their decisions. Both companies have

The list of Dividend Kings -- the very few U.S.-traded stocks that have enacted dividend raises at least once annually for a minimum of 50 years in a row -- is extremely short. That's why it's quite

The S&P 500 is offering a skinny yield of 1.2%. The average healthcare stock has a yield of 1.7%. Healthcare giant Pfizer (NYSE: PFE) is yielding a relatively huge 7.2%. Before you jump at that

The new generation of effective weight loss drugs has generated billions of dollars for industry leaders Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO), and opened the door for companies such as

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) have risen more than 2,000% over the past 20 years. Despite a terrific run-up, it's hard to find an investment bank analyst on Wall Street who expects

Between labor-market data and potential interest-rate cuts, Wall Street has a lot on its plate right now. In an environment like this one, it can be helpful to invest in solid, dividend-paying

The stock market trended higher in August. The popular S&P 500 (SNPINDEX: ^GSPC) index gained 1.9% last month. As of September 10, it has seen a total return of 20.6% in 52 weeks.

The top three

Some decisions are tough to make. Others are so easy that they don't require much thought and are practically no-brainers.

Three Motley Fool contributors believe they've identified dividend stocks

Ken Griffin is the founder and CEO of Citadel, a hedge fund established in 1990, whose long-term performance has been excellent. Citadel's track record suggests that Griffin knows a thing or two

If you're a long-term investor, why should you be paying closer attention to pharmaceutical giant Pfizer (NYSE: PFE)? Because of its dividend, of course! Pfizer's dividend yield is hovering around a

A star stock during the pandemic era wasn't shining so brightly on Friday. On a media report that the current presidential administration is preparing to link a set of fatalities to Covid vaccines

AbbVie (NYSE: ABBV) is a drug company, spun off from Abbott Laboratories in 2013, that you might want to consider for your long-term portfolio. One of the biggest green flags for investing in the

UnitedHealth Group (NYSE: UNH) stock is popping on the back of positive developments.

*Stock prices used were the afternoon prices of Sept. 8, 2025. The video was published on Sept. 10, 2025.